Literature DB >> 6611311

Pulmonary clearance of encapsulated and unencapsulated Haemophilus influenzae strains.

G B Toews, S Viroslav, D A Hart, E J Hansen.   

Abstract

A mouse model system was employed to investigate the temporal pattern of pulmonary clearance of Haemophilus influenzae and to evaluate the effect of the type b polysaccharide capsule on this clearance pattern. The lungs of BALB/c mice were inoculated with boluses of several different H. influenzae strains via an endobronchial catheter. A fully encapsulated H. influenzae type b strain multiplied readily in the lungs for at least 6 h and then was eventually cleared from the lungs over the next 18 h. The pulmonary clearance pattern obtained with an unencapsulated variant of this H. influenzae type b strain was identical to that obtained with the fully encapsulated parent strain. Two nontypable H. influenzae strains isolated by transtracheal aspiration of patients with acute H. influenzae pneumonia also multiplied in the lung and resisted significant clearance for at least 6 h after inoculation. Bolus deposition of either H. influenzae type b or nontypable H. influenzae in the lungs resulted in an eventual influx of polymorphonuclear leukocytes into the alveoli. The observed delay in clearance of all these strains suggests that resident host defense mechanisms must be augmented for clearance to occur. Furthermore, these data indicate that one or more factors other than the Haemophilus capsule are important bacterial determinants of pulmonary clearance of H. influenzae.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6611311      PMCID: PMC263251          DOI: 10.1128/iai.45.2.437-442.1984

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  34 in total

1.  Determinants of lung bacterial clearance in normal mice.

Authors:  S J Jay; W G Johanson; A K Pierce; J S Reisch
Journal:  J Clin Invest       Date:  1976-04       Impact factor: 14.808

2.  Haemophilus influenzae meningitis in infant rats after intranasal inoculation.

Authors:  E R Moxon; A L Smith; D R Averill; D H Smith
Journal:  J Infect Dis       Date:  1974-02       Impact factor: 5.226

3.  Phagocytic and bactericidal activities of peritoneal and alveolar macrophages from mice.

Authors:  M Degré
Journal:  J Med Microbiol       Date:  1969-08       Impact factor: 2.472

4.  The association of bacteremic Haemophilus influenzae pneumonia in adults with typable strains.

Authors:  R Quintiliani; P J Hymans
Journal:  Am J Med       Date:  1971-06       Impact factor: 4.965

5.  Hemophilus influenzae pneumonia in adults.

Authors:  R J Wallace; D M Musher; R R Martin
Journal:  Am J Med       Date:  1978-01       Impact factor: 4.965

6.  Pulmonary clearance of Pseudomonas aeruginosa.

Authors:  P M Southern; B B Mays; A K Pierce; J P Sanford
Journal:  J Lab Clin Med       Date:  1970-10

7.  Comparison of the virulence of O:9,12 and O:4,5,12 Salmonella typhimurium his+ transductants for mice.

Authors:  M B Lyman; B A Stocker; R J Roantree
Journal:  Infect Immun       Date:  1977-02       Impact factor: 3.441

8.  The role of encapsulation and host age in the clearance of Haemophilus influenzae bacteremia.

Authors:  P F Weller; A L Smith; P Anderson; D H Smith
Journal:  J Infect Dis       Date:  1977-01       Impact factor: 5.226

9.  Bacteremic hemophilus influenzae pneumonia in adults. A report of 24 cases and a review of the literature.

Authors:  D C Levin; M I Schwarz; R A Matthay; F M LaForce
Journal:  Am J Med       Date:  1977-02       Impact factor: 4.965

10.  Immunogenic proteins in cell-free culture supernatants of Haemophilus influenzae type b.

Authors:  P A Gulig; G H McCracken; P L Holmans; E J Hansen
Journal:  Infect Immun       Date:  1984-04       Impact factor: 3.441

View more
  9 in total

1.  Antigenic characterization of the oligosaccharide portion of the lipooligosaccharide of nontypable Haemophilus influenzae.

Authors:  C C Patrick; A Kimura; M A Jackson; L Hermanstorfer; A Hood; G H McCracken; E J Hansen
Journal:  Infect Immun       Date:  1987-12       Impact factor: 3.441

2.  Lipooligosaccharides containing phosphorylcholine delay pulmonary clearance of nontypeable Haemophilus influenzae.

Authors:  Bing Pang; Dana Winn; Ryan Johnson; Wenzhou Hong; Shayla West-Barnette; Nancy Kock; W Edward Swords
Journal:  Infect Immun       Date:  2008-03-17       Impact factor: 3.441

3.  Nontypeable Haemophilus influenzae: pathogenesis and prevention.

Authors:  A R Foxwell; J M Kyd; A W Cripps
Journal:  Microbiol Mol Biol Rev       Date:  1998-06       Impact factor: 11.056

4.  Diminished ICAM-1 expression and impaired pulmonary clearance of nontypeable Haemophilus influenzae in a mouse model of chronic obstructive pulmonary disease/emphysema.

Authors:  Bing Pang; Wenzhou Hong; Shayla L West-Barnette; Nancy D Kock; W Edward Swords
Journal:  Infect Immun       Date:  2008-09-15       Impact factor: 3.441

5.  Effect of systemic immunization on pulmonary clearance of Haemophilus influenzae type b.

Authors:  G B Toews; D A Hart; E J Hansen
Journal:  Infect Immun       Date:  1985-05       Impact factor: 3.441

6.  Role of C5 and recruited neutrophils in early clearance of nontypable Haemophilus influenzae from murine lungs.

Authors:  G B Toews; W C Vial; E J Hansen
Journal:  Infect Immun       Date:  1985-10       Impact factor: 3.441

7.  Immune enhancement of pulmonary clearance of nontypable Haemophilus influenzae.

Authors:  E J Hansen; D A Hart; J L McGehee; G B Toews
Journal:  Infect Immun       Date:  1988-01       Impact factor: 3.441

8.  Tracking insertion mutants within libraries by deep sequencing and a genome-wide screen for Haemophilus genes required in the lung.

Authors:  Jeffrey D Gawronski; Sandy M S Wong; Georgia Giannoukos; Doyle V Ward; Brian J Akerley
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-04       Impact factor: 11.205

Review 9.  The regulation of pulmonary immunity.

Authors:  M F Lipscomb; D E Bice; C R Lyons; M R Schuyler; D Wilkes
Journal:  Adv Immunol       Date:  1995       Impact factor: 3.543

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.